Israel-based DayTwo, a microbiome human discovery platform, has secured $31 million in Series B financing. The lead investors were aMoon and Ofek Ventures.
Source: Press Release
Israel-based DayTwo, a microbiome human discovery platform, has secured $31 million in Series B financing. The lead investors were aMoon and Ofek Ventures.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination